ID

17699

Description

Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.; ODM derived from: https://clinicaltrials.gov/show/NCT00409760

Link

https://clinicaltrials.gov/show/NCT00409760

Keywords

Versions (1)
  1. 9/28/16 9/28/16 -
Uploaded on

September 28, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hypertension NCT00409760

English

Eligibility Hypertension NCT00409760

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
outpatients 18 years and older.
Description

Outpatients | Age

Data type

boolean

Alias
UMLS CUI [1]
C0029921
UMLS CUI [2]
C0001779
male or female patients are eligible.
Description

Gender

Data type

boolean

Alias
UMLS CUI [1]
C0079399
female patients must be either post-menopausal for one year or surgically sterile, or using effective contraceptive methods such as barrier method with spermicide or an intra-uterine device. hormonal contraceptive use is disallowed.
Description

Gender | Postmenopausal state | Female Sterilization | Contraceptive methods | Contraception, Barrier | Vaginal Spermicides | Intrauterine Devices | Contraceptives, Oral, Hormonal

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0232970
UMLS CUI [3]
C0015787
UMLS CUI [4]
C0700589
UMLS CUI [5]
C0004764
UMLS CUI [6]
C0087145
UMLS CUI [7]
C0021900
UMLS CUI [8]
C0009907
patients with mild to moderate essential diastolic hypertension (grades 1 and 2 who classification) measured by calibrated standard sphygmomanometer.
Description

essential diastolic hypertension Mild | essential diastolic hypertension Moderate | Measurement Sphygmomanometer Standard

Data type

boolean

Alias
UMLS CUI [1,1]
C3694763
UMLS CUI [1,2]
C2945599
UMLS CUI [2,1]
C3694763
UMLS CUI [2,2]
C0205081
UMLS CUI [3,1]
C0242485
UMLS CUI [3,2]
C0183427
UMLS CUI [3,3]
C1442989
patients must have a msdbp >= 90 mmhg and < 110 mmhg at visit 1 (week -2 to -4), and a msdbp >= 95 mmhg and < 110 mmhg at visit 2 (week 0).
Description

Sitting diastolic blood pressure mean visit 1 | Sitting diastolic blood pressure mean visit 2

Data type

boolean

Alias
UMLS CUI [1,1]
C1319894
UMLS CUI [1,2]
C0444504
UMLS CUI [1,3]
C3842539
UMLS CUI [2,1]
C1319894
UMLS CUI [2,2]
C0444504
UMLS CUI [2,3]
C3842538
patients must have an absolute difference of =< 10 mmhg in their average sitting diastolic blood pressure between visits 1 and 2.
Description

Sitting diastolic blood pressure Average | Difference Absolute visit 1 visit 2

Data type

boolean

Alias
UMLS CUI [1,1]
C1319894
UMLS CUI [1,2]
C1510992
UMLS CUI [2,1]
C1705242
UMLS CUI [2,2]
C0205344
UMLS CUI [2,3]
C3842539
UMLS CUI [2,4]
C3842538
patients who are eligible and able to participate in the study, and who consent to do so after the purpose and nature of the investigation has been clearly explained to them (written informed consent).
Description

Compliance behavior | Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C1321605
UMLS CUI [2]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
severe hypertension (grade 3 who classification; msdbp >=110 mmhg diastolic and/or mssbp >= 180 mmhg systolic).
Description

Hypertension, severe | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean

Data type

boolean

Alias
UMLS CUI [1]
C4013784
UMLS CUI [2,1]
C1319894
UMLS CUI [2,2]
C0444504
UMLS CUI [3,1]
C1319893
UMLS CUI [3,2]
C0444504
inability to discontinue all prior anti-hypertensive medications safely for a period of 14 weeks).
Description

Antihypertensive Agents Discontinue Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0003364
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C1299582
known keith-wagener grade iii or iv hypertensive retinopathy.
Description

Retinopathy hypertensive grade 3 | Retinopathy hypertensive grade 4

Data type

boolean

Alias
UMLS CUI [1]
C0857534
UMLS CUI [2]
C0857415
history of hypertensive encephalopathy or cerebrovascular accident at anytime prior to visit 1 (week -2 to -4).
Description

Hypertensive Encephalopathy | Cerebrovascular accident

Data type

boolean

Alias
UMLS CUI [1]
C0151620
UMLS CUI [2]
C0038454
transient ischemic cerebral attack during the last 12 months prior to visit 1 (week-2 to -4).
Description

Transient Ischemic Attack

Data type

boolean

Alias
UMLS CUI [1]
C0007787
evidence of a secondary form of hypertension, such as coarctation of the aorta, hyperaldosteronism, unilateral renal artery stenosis, or pheochromocytoma, etc.
Description

Secondary hypertension Evidence of | Aortic coarctation | Hyperaldosteronism | Unilateral renal artery stenosis | Pheochromocytoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0155616
UMLS CUI [1,2]
C0332120
UMLS CUI [2]
C0003492
UMLS CUI [3]
C0020428
UMLS CUI [4]
C0856759
UMLS CUI [5]
C0031511
type 1 diabetes mellitus.
Description

Diabetes Mellitus, Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0011854
type 2 diabetes mellitus with poor glucose control as defined by fasting glycosylated hemoglobin (hba1c) >8% at visit 1 (week -2 to -4).
Description

Diabetes Mellitus, Non-Insulin-Dependent | GLUCOSE CONTROL Poor | Glycosylated hemoglobin A Fasting

Data type

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0726398
UMLS CUI [2,2]
C0542537
UMLS CUI [3,1]
C0019018
UMLS CUI [3,2]
C0015663
administration of any agent indicated for the treatment of hypertension within a minimum 4 weeks prior to randomization into the study (visit 2, week 0), with the permitted exception of those anti-hypertensive medications requiring tapering down commencing at visit 0 (week -4 to -6).
Description

Antihypertensive Agents

Data type

boolean

Alias
UMLS CUI [1]
C0003364
known or suspected contraindications, including history of allergy to angiotensin receptor blockers or calcium channel blockers.
Description

Medical contraindication | Hypersensitivity Angiotensin II receptor antagonist | Hypersensitivity Calcium Channel Blockers

Data type

boolean

Alias
UMLS CUI [1]
C1301624
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0521942
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0006684
other protocol-defined inclusion/exclusion criteria may apply
Description

Inclusion criteria Study Protocol | Exclusion Criteria Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C2348563
UMLS CUI [2,1]
C0680251
UMLS CUI [2,2]
C2348563
Back to the top of the page

Similar models

Eligibility Hypertension NCT00409760

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Outpatients | Age
Item
outpatients 18 years and older.
boolean
C0029921 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Gender
Item
male or female patients are eligible.
boolean
C0079399 (UMLS CUI [1])
Gender | Postmenopausal state | Female Sterilization | Contraceptive methods | Contraception, Barrier | Vaginal Spermicides | Intrauterine Devices | Contraceptives, Oral, Hormonal
Item
female patients must be either post-menopausal for one year or surgically sterile, or using effective contraceptive methods such as barrier method with spermicide or an intra-uterine device. hormonal contraceptive use is disallowed.
boolean
C0079399 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0015787 (UMLS CUI [3])
C0700589 (UMLS CUI [4])
C0004764 (UMLS CUI [5])
C0087145 (UMLS CUI [6])
C0021900 (UMLS CUI [7])
C0009907 (UMLS CUI [8])
essential diastolic hypertension Mild | essential diastolic hypertension Moderate | Measurement Sphygmomanometer Standard
Item
patients with mild to moderate essential diastolic hypertension (grades 1 and 2 who classification) measured by calibrated standard sphygmomanometer.
boolean
C3694763 (UMLS CUI [1,1])
C2945599 (UMLS CUI [1,2])
C3694763 (UMLS CUI [2,1])
C0205081 (UMLS CUI [2,2])
C0242485 (UMLS CUI [3,1])
C0183427 (UMLS CUI [3,2])
C1442989 (UMLS CUI [3,3])
Sitting diastolic blood pressure mean visit 1 | Sitting diastolic blood pressure mean visit 2
Item
patients must have a msdbp >= 90 mmhg and < 110 mmhg at visit 1 (week -2 to -4), and a msdbp >= 95 mmhg and < 110 mmhg at visit 2 (week 0).
boolean
C1319894 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C3842539 (UMLS CUI [1,3])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C3842538 (UMLS CUI [2,3])
Sitting diastolic blood pressure Average | Difference Absolute visit 1 visit 2
Item
patients must have an absolute difference of =< 10 mmhg in their average sitting diastolic blood pressure between visits 1 and 2.
boolean
C1319894 (UMLS CUI [1,1])
C1510992 (UMLS CUI [1,2])
C1705242 (UMLS CUI [2,1])
C0205344 (UMLS CUI [2,2])
C3842539 (UMLS CUI [2,3])
C3842538 (UMLS CUI [2,4])
Compliance behavior | Informed Consent
Item
patients who are eligible and able to participate in the study, and who consent to do so after the purpose and nature of the investigation has been clearly explained to them (written informed consent).
boolean
C1321605 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Hypertension, severe | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean
Item
severe hypertension (grade 3 who classification; msdbp >=110 mmhg diastolic and/or mssbp >= 180 mmhg systolic).
boolean
C4013784 (UMLS CUI [1])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319893 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
Antihypertensive Agents Discontinue Unable
Item
inability to discontinue all prior anti-hypertensive medications safely for a period of 14 weeks).
boolean
C0003364 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Retinopathy hypertensive grade 3 | Retinopathy hypertensive grade 4
Item
known keith-wagener grade iii or iv hypertensive retinopathy.
boolean
C0857534 (UMLS CUI [1])
C0857415 (UMLS CUI [2])
Hypertensive Encephalopathy | Cerebrovascular accident
Item
history of hypertensive encephalopathy or cerebrovascular accident at anytime prior to visit 1 (week -2 to -4).
boolean
C0151620 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
Transient Ischemic Attack
Item
transient ischemic cerebral attack during the last 12 months prior to visit 1 (week-2 to -4).
boolean
C0007787 (UMLS CUI [1])
Secondary hypertension Evidence of | Aortic coarctation | Hyperaldosteronism | Unilateral renal artery stenosis | Pheochromocytoma
Item
evidence of a secondary form of hypertension, such as coarctation of the aorta, hyperaldosteronism, unilateral renal artery stenosis, or pheochromocytoma, etc.
boolean
C0155616 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0003492 (UMLS CUI [2])
C0020428 (UMLS CUI [3])
C0856759 (UMLS CUI [4])
C0031511 (UMLS CUI [5])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes mellitus.
boolean
C0011854 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | GLUCOSE CONTROL Poor | Glycosylated hemoglobin A Fasting
Item
type 2 diabetes mellitus with poor glucose control as defined by fasting glycosylated hemoglobin (hba1c) >8% at visit 1 (week -2 to -4).
boolean
C0011860 (UMLS CUI [1])
C0726398 (UMLS CUI [2,1])
C0542537 (UMLS CUI [2,2])
C0019018 (UMLS CUI [3,1])
C0015663 (UMLS CUI [3,2])
Antihypertensive Agents
Item
administration of any agent indicated for the treatment of hypertension within a minimum 4 weeks prior to randomization into the study (visit 2, week 0), with the permitted exception of those anti-hypertensive medications requiring tapering down commencing at visit 0 (week -4 to -6).
boolean
C0003364 (UMLS CUI [1])
Medical contraindication | Hypersensitivity Angiotensin II receptor antagonist | Hypersensitivity Calcium Channel Blockers
Item
known or suspected contraindications, including history of allergy to angiotensin receptor blockers or calcium channel blockers.
boolean
C1301624 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0521942 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0006684 (UMLS CUI [3,2])
Inclusion criteria Study Protocol | Exclusion Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1512693 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0680251 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial